Trial intelligence / Profile preview

Hemangiol for high-risk infantile hemangioma

2014-005555-80Phase 3Completed

Sponsor
Pierre Fabre Dermatologie
Start
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of propranolol in Capillary Haemangioma, sponsored by Pierre Fabre Dermatologie. Started Apr 2015; status: completed.

02

Drugs

propranolol
03

Conditions

Capillary Haemangioma

Beyond the preview

Go deeper on 2014-005555-80.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005555-80.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call